pharm-analyt Working on its Key Account and Overall Strategy: A process having started on 3 April 2024 with an external consultant will be concluded by 30 November 2024
Refining the Overall Strategy after 38 Years
Previous
Previous
Publication researching Fabry disease
Next
Next